| Date | Quarter | Session | EPS (est → actual) | Revenue (est → actual) |
|---|---|---|---|---|
| Oct 26, 2026Next | Q3 2026 | — | 0.65 | 3.66 B |
Sep 1, 2026
Toyota Motor's hybrid growth and expanded value-chain businesses support demand, but higher costs, China weakness and leverage temper prospects.
Welltower (WELL) and other senior housing REITs could see stronger growth in 2027 as occupancy rises
Morgan Stanley analyst Ronald Kamdem maintains Welltower (NYSE:WELL) with a Overweight and raises the price target from $215 to $251.
Wells Fargo analyst John Kilichowski maintains Welltower (NYSE:WELL) with a Overweight and raises the price target from $237 to $266.
Aug 31, 2026
Welltower (WELL) scores High Growth Momentum 6, Technical 10, Setup 8, combining accelerating sales with a tightening chart setup. A top pick for growth-plus-timing investors.
Barclays analyst Richard Hightower maintains Welltower (NYSE:WELL) with a Equal-Weight and raises the price target from $254 to $259.
Aug 28, 2026
Welltower (WELL) trades at extreme REIT valuations despite strong SHOP NOI and dividend growth.
Aug 27, 2026
Welltower (NYSE:WELL) has outperformed the market over the past 20 years by 3.33% on an annualized basis producing an average annual return of 12.57%. Currently, Welltower has a market capitalization of $172.74 billion.
Aug 13, 2026
Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Opportunity Fund”. A copy of the letter is available to download here. During the second quarter, the Baron Opportunity Fund increased 27.07% (Institutional Shares), outperforming both the Russell 3000 Growth Index (17.05%) and the S&P 500 Index (15.20%). For the […]
Aug 11, 2026
Welltower has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.
Aug 10, 2026
WELL Health Technologies (TSE:WELL) reported second-quarter revenue of approximately C$404 million, up 12% from a year earlier, while adjusted EBITDA was C$48.1 million, down 3% on a reported basis. The company raised its full-year 2026 adjusted EBITDA outlook by C$10 million, citing stronger execut
Aug 8, 2026
Earnings event puts WELL Health Technologies under the microscope WELL Health Technologies (TSX:WELL) has stepped into the spotlight after reporting second quarter 2026 results that paired record quarterly revenue with a move from profit to loss. The company posted Q2 sales of CA$400.43 million compared with CA$356.67 million a year earlier, while net results shifted from income of CA$12.15 million to a net loss of CA$10.91 million. On a per share basis, basic and diluted loss from continuing...
Aug 6, 2026
Welltower (NYSE:WELL) has outperformed the market over the past 15 years by 8.46% on an annualized basis producing an average annual return of 21.77%. Currently, Welltower has a market capitalization of $171.83 billion.
